Surprised that dementia drug was rejected
DEMENTIA Australia expressed disappointment over the Therapeutic Goods Administration’s (TGA) rejection of Lecanemab, a treatment for early-stage Alzheimer’s disease. Developed ...
Read more about Surprised that dementia drug was rejected


